. . . . . . . "[Furthermore, homozygous ApoE ?4/4 individuals diagnosed with AD are known to have heightened amyloid burden and a more rapid rate of cognitive decline relative to heterozygous ?3/4 ApoE carriers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:10:33+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .